Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
MUMBAI: A day after semaglutide lost patent protection in India, top drugmakers including Dr Reddys, Sun Pharma, and Zydus Lifesciences launched generic versions priced 50-90% below the innovator brands, kicking off an aggressive scramble for share in the fast-growing weight-loss and diabetes market
R.LyraE
The "master antioxidant" simply wasn't making it past the gut
21 Liraglutide showed no effect on the hierarchical primary endpoint of time to death, time to rehospitalisation for HF and time-averaged change in N-terminal pro B-type natriuretic peptide (NT-proBNP) from baseline to 180 days (p=0.31), with even an increased risk of emergency department visit, HF hospitalisation or all-cause death events (HR 1.36
US$ 29.89
US$ 22.91
US$ 21.67
US$ 21.93
US$ 25.51
US$ 27.64
US$ 29.95
US$ 29.15
